Mutations of the PIK3CA gene in human cancers

Phosphatidylinositol 3-kinases (PI3Ks) are known to be important regulators of signaling pathways. To determine whether PI3Ks are genetically altered in cancers, we analyzed the sequences of the P13K gene family and discovered that one family member, PIK3CA, is frequently mutated in cancers of the colon and other organs. The majority of mutations clustered near two positions within the P13K helical or kinase domains. PIK3CA represents one of the most highly mutated oncogenes yet identified in human cancers and is useful as a diagnostic and therapeutic target.

Attached files:


Patents:
AU 2,011,200,600

Inventor(s): SAMUELS YARDENA; VELCULESCU VICTOR; KINZLER KENNETH W; VOGELSTEIN BERT

Type of Offer: Licensing



« More Diagnostic Patents

---